SUMO-1, Human, mAb 1B12-E2,Hycult Biotech,HM2327
Post-translational modification regulated by conjugation of a small ubiquitin-like modifier (SUMO) is involved in various cellular processes such as transcriptional regulation, apoptosis and nuclear transport. Recent proteomic analyses in mammalian cells revealed that a number of SUMO substrates and specific modifications by SUMO-1 are involved in essential processes, including chromatin organization, transcription, RNA metabolism, immunomodulation and development of the innate immune system.
Host
Human
Platform ID
BAB198684110

Hycult Biotech
Contact
Tel: +31 (0)413 251335
Fax: +31(0)413 248353
Email:
Product Specifications
Specifications
NameSUMO-1, Human, mAb 1B12-E2
Cat. No.HM2327
HostHuman
IsotypeMouse IgG3
Formulation0.2 ml (100 µg/ml) 0.2 µm filtered antibody solution in PBS, containing 0.1% bovine serum albumin and 0.02% sodium azide.
StorageProduct should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.
